Stéphane Schneebeli
2 Papers
Stéphane Schneebeli is an academic researcher. The author has contributed to research in topics: Insulin resistance & Randomized controlled trial. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
Guillaume Treiber,Ania Flaus Furmaniuk,Alice Guilleux,Samir Medjane,Oriane Bonfanti,Stéphane Schneebeli,Céline Bernard,Nathalie Le-Moullec,Faouzi Bakiri,Maryse Pholsena,Olivier Rollot,Camille Vatier,Eric Jarlet,Isabelle Jéru,Olivier Lascols,Françoise Darcel,Bhoopendrasing Domun,Adrien Venault,Sophie Venault,Marie-Line Jacquemont,Bérénice Doray,Jean-Christophe Maiza,M. Cogne,Corinne Vigouroux,Estelle Nobecourt,Estelle Nobecourt +25 more
TL;DR: In this article, the level of expression of the LMNA 'Reunionese' variant determines the severity of both lipoatrophy and metabolic complications, leading to death in four cases.
16
Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Réunion Randomized Controlled Trial
Florent Besnier,Victorine Lenclume,Patrick Gérardin,Adrian Fianu,Jérémy Martinez,N. Naty,S. Porcherat,Karim Boussaïd,Stéphane Schneebeli,Eric Jarlet,Sarah Hatia,Georges Dalleau,Chantal Verkindt,Jean-Frédéric Brun,Marie-Paule Gonthier,François Favier +15 more
TL;DR: The LIPOXmax intervention did not show a superiority in reducing FM in overweight or obese women but is associated with higher MFO and better glucose control improvements, and other studies are required before proposing LipOXmax training for the prevention of T2DM in overweight women.